ANGLE announces partnership with BioView | 19-Apr-2023 | 07:00 | RNS |
Pharma Services Contract with Crescendo Biologics | 13-Apr-2023 | 07:00 | RNS |
Notice of Preliminary Results and Webcast | 03-Apr-2023 | 07:00 | RNS |
Issue of LTIP Options and Share Options | 10-Mar-2023 | 07:00 | RNS |
Holding(s) in Company | 09-Mar-2023 | 15:03 | RNS |
Director/PDMR shareholding | 09-Feb-2023 | 14:44 | RNS |
Appointment of Non-Executive Director | 19-Jan-2023 | 07:00 | RNS |
Holding(s) in Company | 11-Jan-2023 | 17:20 | RNS |
Holding(s) in Company | 10-Jan-2023 | 18:20 | RNS |
Second Price Monitoring Extn | 06-Jan-2023 | 11:05 | RNS |
Price Monitoring Extension | 06-Jan-2023 | 11:00 | RNS |
Second Price Monitoring Extn | 05-Jan-2023 | 09:05 | RNS |
Price Monitoring Extension | 05-Jan-2023 | 09:00 | RNS |
Appointment of Non-Executive Director | 05-Jan-2023 | 07:01 | RNS |
Business Update | 05-Jan-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 17.75p |
Change Today | 4.00p |
% Change | 29.09 % |
52 Week High | 31.40 |
52 Week Low | 9.25 |
Volume | 7,404,983 |
Shares Issued | 260.58m |
Market Cap | £46.25m |
RiskGrade | 312 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:28 | 150,000 @ 17.65p |
14:40 | 100,000 @ 17.00p |
16:29 | 10,000 @ 18.06p |
16:29 | 35,000 @ 18.30p |
16:29 | 15,000 @ 17.88p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research